Virginia Castilla Llorente
Chief Scientific Officer Cambridge Medixine Ltd
Virginia Castilla Llorente is Chief Scientific Officer at CamMed Therapeutics and a biotechnology leader with deep expertise in RNA biology and therapeutic platform development. She has held senior roles at Evox Therapeutics and SymphoRNA, advancing engineered extracellular vesicle and RNA delivery technologies. Virginia completed her PhD at the Severo Ochoa Molecular Biology Centre and conducted postdoctoral research at MSKCC, the Francis Crick Institute and UCL, focusing on microRNA, mRNA biology and gene regulation.
